
|Articles|May 1, 2004
Lens aims to increase range of accommodation
San Francisco-Clinical trials are under way in centers in Germany and Colombia to evaluate a dual-optic accommodating IOL (Synchrony, Visiogen) designed to offer amplified, consistent accommodation across a wide range of IOL powers, said Stephen D. McLeod, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
3
Avisi Technologies releases positive 12-month data from VITA Trial
4
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
5


















































.png)


